Drug | Host country | China | Colombia | Morocco | Poland |
---|---|---|---|---|---|
Alimentary tract and metabolism | Spain | 0.54 (0.49–0.59) | 0.87 (0.83–0.92) | 1.13 (1.09–1.17) | 0.33 (0.29–0.37) |
Norway | 0.65 (0.59–0.71) | 0.97 (0.86–1.11) | 1.71 (1.58–1.84) | 0.35 (0.33–0.36) | |
Blood and blood forming organs | Spain | 0.59 (0.51–0.69) | 0.91 (0.84–0.98) | 1.09 (1.03–1.15) | 0.47 (0.39–0.56) |
Norway | 0.45 (0.39–0.52) | 0.77 (0.61–0.98) | 0.63 (0.55–0.72) | 0.34 (0.31–0.37) | |
Cardiovascular system | Spain | 0.39 (0.33–0.45) | 0.72 (0.68–0.78) | 0.65 (0.61–0.69) | 0.46 (0.39–0.53) |
Norway | 0.55 (0.50–0.61) | 0.69 (0.57–0.83) | 0.70 (0.63–0.77) | 0.35 (0.33–0.37) | |
Dermatologicals | Spain | 0.60 (0.54–0.67) | 0.91 (0.86–0.96) | 1.16 (1.11–1.21) | 0.35 (0.3–0.41) |
Norway | 0.81 (0.75–0.87) | 0.88 (0.80–0.97) | 1.09 (1.00–1.18) | 0.32 (0.3–0.33) | |
Genito-urinary system and sex hormones | Spain | 0.50 (0.41–0.61) | 1.49 (1.38–1.60) | 1.79 (1.70–1.89) | 0.57 (0.46–0.71) |
Norway | 0.28 (0.26–0.31) | 0.80 (0.73–0.88) | 0.70 (0.63–0.76) | 0.26 (0.25–0.27) | |
Systemic hormonal preparations, excluding sex hormones and insulins | Spain | 0.43 (0.37–0.51) | 0.67 (0.61–0.73) | 0.79 (0.75–0.85) | 0.42 (0.35–0.51) |
Norway | 0.47 (0.42–0.54) | 1.06 (0.92–1.23) | 0.87 (0.77–0.98) | 0.3 (0.28–0.33) | |
Antiinfectives for systemic use | Spain | 0.29 (0.26–0.31) | 0.57 (0.55–0.60) | 0.84 (0.81–0.86) | 0.4 (0.36–0.43) |
Norway | 0.44 (0.41–0.47) | 0.89 (0.83–0.96) | 0.92 (0.86–0.98) | 0.35 (0.33–0.36) | |
Antineoplastic and immunomodulating agents | Spain | 0.12 (0.04–0.36) | 0.61 (0.46–0.82) | 0.47 (0.37–0.61) | 0.24 (0.1–0.57) |
Norway | 0.40 (0.27–0.56) | 1.05 (0.71–1.54) | 0.53 (0.38–0.75) | 0.23 (0.19–0.28) | |
Musculo-skeletal system | Spain | 0.32 (0.29–0.35) | 0.75 (0.72–0.78) | 1.15 (1.11–1.18) | 0.38 (0.34–0.41) |
Norway | 0.39 (0.36–0.43) | 0.96 (0.88–1.06) | 1.18 (1.10–1.26) | 0.33 (0.32–0.34) | |
Nervous system | Spain | 0.36 (0.33–0.40) | 0.73 (0.70–0.77) | 1.13 (1.09–1.16) | 0.37 (0.33–0.41) |
Norway | 0.29 (0.27–0.32) | 1.29 (1.19–1.39) | 1.36 (1.28–1.45) | 0.31 (0.3–0.32) | |
Antiparasitic products, insecticides and repellents | Spain | 0.41 (0.25–0.68) | 0.94 (0.76–1.16) | 1.15 (0.99–1.33) | 0.33 (0.17–0.64) |
Norway | 0.53 (0.43–0.67) | 1.35 (1.11–1.64) | 0.88 (0.71–1.08) | 0.34 (0.3–0.38) | |
Respiratory system | Spain | 0.40 (0.37–0.44) | 0.56 (0.53–0.59) | 0.63 (0.61–0.65) | 0.28 (0.25–0.31) |
Norway | 0.64 (0.61–0.70) | 1.11 (1.04–1.19) | 0.92 (0.86–0.99) | 0.25 (0.24–0.26) | |
Sensory organs | Spain | 0.45 (0.40–0.51) | 0.69 (0.65–0.74) | 0.93 (0.88–0.97) | 0.21 (0.17–0.26) |
Norway | 0.67 (0.62–0.72) | 1.15 (1.05–1.26) | 1.09 (1.01–1.20) | 0.28 (0.26–0.29) |